Johnson & Johnson: Clinical study of potential coronavirus vaccine could start by end of year

Johnson & Johnson (NYSE:JNJ) said today that its Janssen Pharmaceutical Cos. has forged a partnership with the Beth Israel Deaconess Medical Center (BIDMC) to support coronavirus vaccine development.

Leave a Reply

Your email address will not be published. Required fields are marked *